Vanda Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Vanda Pharmaceuticals patents 89 in total

Status Patent
Application
Utility: Treatment of Affective Disorders External link
Filling date: 6 Sep 2025 Issue date: 8 Sep 2022
Application
Utility: METHODS FOR THE ADMINISTRATION OF ILOPERIDONE External link
Filling date: 6 Sep 2025 Issue date: 18 Aug 2022
Application
Utility: USE OF TRADIPITANT IN MOTION SICKNESS External link
Filling date: 6 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: METHOD OF TREATMENT WITH TRADIPITANT External link
Filling date: 6 Sep 2025 Issue date: 21 Jul 2022
Application
Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 2 Jun 2022
Application
Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 2 Jun 2022
Grant
Utility: Method of treatment with tradipitant External link
Filling date: 6 Sep 2025 Issue date: 10 May 2022
Application
Utility: METHOD OF TREATMENT External link
Filling date: 6 Sep 2025 Issue date: 5 May 2022
Application
Utility: METHOD OF TREATMENT WITH TRADIPITANT External link
Filling date: 6 Sep 2025 Issue date: 31 Mar 2022
Grant
Utility: Treatment of circadian rhythm disorders External link
Filling date: 6 Sep 2025 Issue date: 29 Mar 2022
Application
Utility: GENETIC MARKERS FOR ENHANCING EFFICACY OF ANTIPSYCHOTIC TREATMENT WITH ILOPERIDONE External link
Filling date: 6 Sep 2025 Issue date: 17 Mar 2022
Application
Utility: HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON External link
Filling date: 6 Sep 2025 Issue date: 10 Mar 2022
Grant
Utility: Method of treatment External link
Filling date: 6 Sep 2025 Issue date: 8 Mar 2022
Application
Utility: METHOD OF IMPROVING SLEEP External link
Filling date: 6 Sep 2025 Issue date: 10 Feb 2022
Grant
Utility: Genetic markers for enhancing efficacy of antipsychotic treatment with iloperidone External link
Filling date: 6 Sep 2025 Issue date: 4 Jan 2022
Grant
Utility: Liquid tasimelteon formulations and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 21 Dec 2021
Grant
Utility: Highly purified pharmaceutical grade tasimelteon External link
Filling date: 6 Sep 2025 Issue date: 21 Dec 2021
Application
Utility: METHOD OF TREATMENT External link
Filling date: 6 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: TREATMENT OF DISORDERS WITH TASIMELTEON External link
Filling date: 6 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: Improving Sleep or Post-Sleep Performance External link
Filling date: 6 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: METHOD OF TREATMENT WITH TRADIPITANT External link
Filling date: 6 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: CANCER TREATMENT External link
Filling date: 6 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: TREATMENT OF SCHIZOPHRENIA External link
Filling date: 6 Sep 2025 Issue date: 21 Oct 2021
Grant
Utility: Method of treatment External link
Filling date: 6 Sep 2025 Issue date: 12 Oct 2021
Application
Utility: METHOD OF TREATMENT External link
Filling date: 6 Sep 2025 Issue date: 30 Sep 2021
Application
Utility: DEPOT ADMINISTRATION OF ILOPERIDONE External link
Filling date: 6 Sep 2025 Issue date: 23 Sep 2021
Application
Utility: PREDICTION OF SLEEP PARAMETER AND RESPONSE TO SLEEP-INDUCING COMPOUND BASED ON PER3 VNTR GENOTYPE External link
Filling date: 6 Sep 2025 Issue date: 9 Sep 2021
Grant
Utility: Treatment of circadian rhythm disorders External link
Filling date: 6 Sep 2025 Issue date: 17 Aug 2021
Grant
Utility: Cancer treatment External link
Filling date: 6 Sep 2025 Issue date: 3 Aug 2021
Application
Utility: METHOD OF TREATMENT WITH TRADIPITANT External link
Filling date: 6 Sep 2025 Issue date: 29 Jul 2021
Grant
Utility: Treatment of schizophrenia External link
Filling date: 6 Sep 2025 Issue date: 27 Jul 2021
Application
Utility: Liquid Tasimelteon Formulations and Methods of Use Thereof External link
Filling date: 6 Sep 2025 Issue date: 15 Jul 2021
Application
Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 8 Jul 2021
Application
Utility: METHODS FOR THE ADMINISTRATION OF ILOPERIDONE External link
Filling date: 6 Sep 2025 Issue date: 24 Jun 2021
Application
Utility: Liquid Tasimelteon Formulations and Methods of Use Thereof External link
Filling date: 6 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: DEPOT ADMINISTRATION OF ILOPERIDONE External link
Filling date: 6 Sep 2025 Issue date: 3 Jun 2021
Application
Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 3 Jun 2021
Grant
Utility: Method of treatment External link
Filling date: 6 Sep 2025 Issue date: 25 May 2021
Application
Utility: TREATMENT OF CIRCADIAN RHYTHM DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 6 May 2021
Grant
Utility: Iloperidone for the treatment of schizophrenia External link
Filling date: 6 Sep 2025 Issue date: 27 Apr 2021
Grant
Utility: Treatment of circadian rhythm disorders External link
Filling date: 6 Sep 2025 Issue date: 20 Apr 2021
Application
Utility: METHOD OF TREATMENT OF SCHIZOPHRENIA External link
Filling date: 6 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: METHOD OF TREATMENT WITH TRADIPITANT External link
Filling date: 6 Sep 2025 Issue date: 1 Apr 2021
Grant
Utility: Treatment of circadian rhythm disorders External link
Filling date: 6 Sep 2025 Issue date: 16 Mar 2021
Application
Utility: IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT External link
Filling date: 6 Sep 2025 Issue date: 4 Mar 2021
Application
Utility: Treatment of Affective Disorders External link
Filling date: 6 Sep 2025 Issue date: 4 Mar 2021
Application
Utility: HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON External link
Filling date: 6 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 21 Jan 2021

Showing 1 to 50 of 89 patents.